Correction to: Breast Cancer https://doi.org/10.1007/s12282-021-01241-0

In the original publication of the article, the first sentence in the heading “Conclusions” in “Abstract” section should be changed as “In ER-positive breast cancer, Wnt5a upregulates the CYP metabolic pathway and decrease the sensitivity to tamoxifen, paclitaxel, and cyclophosphamide, all of the three, standard treatment methods for ER-positive breast cancer.”